Evaluating the Uptake of Instruction for Office-based Opioid Addiction Practices Aimed at Decreasing and Preventing Buprenorphine Diversion and Misuse

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/087/31/10

Funding

  • Reckitt Benckiser Pharmaceuticals Inc: $328,998.00